Scott Bell

Citée par

	Toutes	Depuis 2019
Citations	21018	11326
indice h	69	46
indice i10	208	160

2200

1100

550

1650

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202460 85 106 184 164 221 242 293 310 359 417 587 776 756 1058 1140 1230 1381 1509 1874 2126 2047 2090 1647

Accès public

Tout afficher

94 articles

21 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

J Stuart ElbornImperial College and Royal Brompton Hospital, LondonAdresse e-mail validée de imperial.ac.uk
Chris CoulterInfectious Diseases Physician and consultant Microbiologist;Director Queensland MycobacteriumAdresse e-mail validée de health.qld.gov.au
Distinguished Professor Lidia MorawskaQueensland University of TechnologyAdresse e-mail validée de qut.edu.au
Ristan GreerThe University of QueenslandAdresse e-mail validée de uq.edu.au
Graham Richard JohnsonQueensland University of TechnologyAdresse e-mail validée de qut.edu.au
Michael D NissenAssociate Professor, University of QueenslandAdresse e-mail validée de uq.edu.au
Luke KnibbsAssociate Professor, The University of SydneyAdresse e-mail validée de sydney.edu.au
Anne ChangMenzies School of Health Research; Queensland University of TechnologyAdresse e-mail validée de menzies.edu.au
Simon BowlerRespiratory Medicine, Mater Hospital BrisbaneAdresse e-mail validée de mater.org.au
Shawn AaronOttawa Hospital Research Institute, University of OttawaAdresse e-mail validée de ohri.ca
Derek SarovichUniversity of the Sunshine CoastAdresse e-mail validée de usc.edu.au
Jane DaviesProfessor of Paediatric Respirology & Experimental MedicineAdresse e-mail validée de imperial.ac.uk
Prof. Edward F. McKoneUniversity College DublinAdresse e-mail validée de svhg.ie
Mark ElkinsClinical Associate Professor, University of SydneyAdresse e-mail validée de sydney.edu.au
D R VanDevanterCase Western Reserve University School of MedicineAdresse e-mail validée de case.edu
Susanna A McColleyProfessor of Pediatrics, Northwestern University Feinberg School of MedicineAdresse e-mail validée de northwestern.edu
Michael BoyleJohns Hopkins University School of MedicineAdresse e-mail validée de jhmi.edu
Julia M PotterProfessor of Pathology, ANUAdresse e-mail validée de act.gov.au
Philip SchluterProfessor of Health Sciences, University of Canterbury, New ZealandAdresse e-mail validée de canterbury.ac.nz
Margarida AmaralProfessor of Molecular Biology, Faculty of Sciences, University of LisboaAdresse e-mail validée de fc.ul.pt

Suivre

Scott Bell

Affiliation inconnue

Adresse e-mail validée de health.qld.gov.au


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011	2513	2011
The future of cystic fibrosis care: a global perspective SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ... The Lancet Respiratory Medicine 8 (1), 65-124, 2020	932	2020
ECFS best practice guidelines: the 2018 revision C Castellani, AJA Duff, SC Bell, HGM Heijerman, A Munck, F Ratjen, ... Journal of cystic fibrosis 17 (2), 153-178, 2018	805	2018
European cystic fibrosis society standards of care: best practice guidelines AR Smyth, SC Bell, S Bojcin, M Bryon, A Duff, P Flume, N Kashirskaya, ... Journal of cystic fibrosis 13, S23-S42, 2014	789	2014
Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ... Annals of the American Thoracic Society 16 (1), 22-28, 2019	673	2019
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial J Wolter, S Seeney, S Bell, S Bowler, P Masel, J McCormack Thorax 57 (3), 212-216, 2002	664	2002
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016	561	2016
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised … MP Boyle, SC Bell, MW Konstan, SA McColley, SM Rowe, E Rietschel, ... The lancet Respiratory medicine 2 (7), 527-538, 2014	537	2014
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ... Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999	387	1999
The rise of non-tuberculosis mycobacterial lung disease CN Ratnatunga, VP Lutzky, A Kupz, DL Doolan, DW Reid, M Field, ... Frontiers in immunology 11, 303, 2020	385	2020
Genetic modifiers of liver disease in cystic fibrosis JR Bartlett, KJ Friedman, SC Ling, RG Pace, SC Bell, B Bourke, ... Jama 302 (10), 1076-1083, 2009	351	2009
Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand AB Chang, SC Bell, CA Byrnes, K Grimwood, PW Holmes, PT King, ... Medical Journal of Australia 193, 356-365, 2010	327*	2010
Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions D Hill, B Rose, A Pajkos, M Robinson, P Bye, S Bell, M Elkins, ... Journal of clinical microbiology 43 (10), 5085-5090, 2005	284	2005
Neutrophils in cystic fibrosis DG Downey, SC Bell, JS Elborn Thorax 64 (1), 81-88, 2009	277	2009
New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls SC Bell, K De Boeck, MD Amaral Pharmacology & therapeutics 145, 19-34, 2015	255	2015
Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical … SD Aaron, KL Vandemheen, W Ferris, D Fergusson, E Tullis, D Haase, ... The Lancet 366 (9484), 463-471, 2005	236	2005
Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals DE Leisman, MO Harhay, DJ Lederer, M Abramson, AA Adjei, J Bakker, ... Critical care medicine 48 (5), 623-633, 2020	233	2020
Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study HM Buntain, RM Greer, PJ Schluter, JCH Wong, JA Batch, JM Potter, ... Thorax 59 (2), 149-155, 2004	192	2004
Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources B De Smet, M Mayo, C Peeters, JEA Zlosnik, T Spilker, TJ Hird, JJ LiPuma, ... International Journal of Systematic and Evolutionary Microbiology 65 (Pt_7 …, 2015	189	2015
Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON^®‐CMV S Walker, C Fazou, T Crough, R Holdsworth, P Kiely, M Veale, S Bell, ... Transplant Infectious Disease 9 (2), 165-170, 2007	188	2007

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs